[First Quarter 2025 Financial Performance Overview](index=1&type=section&id=First%20Quarter%202025%20Results) [Results of Operations](index=2&type=section&id=RESULTS%20OF%20OPERATIONS) In the first quarter of 2025, Globe Life reported a net income of $3.01 per diluted common share, a 13% increase year-over-year. Net operating income, a key management metric, rose by 10% to $3.07 per diluted common share, exceeding management's expectations. This growth was primarily driven by a 17% increase in insurance underwriting income per share, although partially offset by lower excess investment income and higher interest on debt Q1 2025 Key Per Share Financial Metrics | Metric | Q1 2025 | Q1 2024 | % Change | | :--- | :--- | :--- | :--- | | Net Income per Diluted Share | $3.01 | $2.67 | 13% | | Net Operating Income per Diluted Share | $3.07 | $2.78 | 10% | | Insurance Underwriting Income per Share | $3.98 | $3.41 | 17% | | Excess Investment Income per Share | $0.42 | $0.46 | (9)% | Q1 2025 Operating Summary (in thousands) | Operating Summary | Q1 2025 | Q1 2024 | % Change | | :--- | :--- | :--- | :--- | | Insurance underwriting income | $336,315 | $324,361 | 4% | | Excess investment income | $35,870 | $43,785 | (18)% | | Net operating income | $259,337 | $264,099 | (2)% | | Net income | $254,563 | $254,217 | 0% | - The company incurred costs of **$4.8 million** related to the settlement of certain litigation claims, which impacted net income[7](index=7&type=chunk)[8](index=8&type=chunk) [Reconciliation of GAAP and Non-GAAP Measures](index=3&type=section&id=MANAGEMENT%20VS.%20GAAP%20MEASURES) The company's net income as a return on equity (ROE) was 19.0% for Q1 2025, compared to 21.3% in the prior year. The non-GAAP measure of net operating income as an ROE (excluding AOCI) was 14.1%, slightly down from 14.3%. Book value per share increased significantly to $64.50 from $53.03 year-over-year, while book value per share excluding AOCI, a key management metric, grew to $87.92 from $79.00 Return on Equity (ROE) Comparison | Metric | Q1 2025 | Q1 2024 | | :--- | :--- | :--- | | Net income as an ROE | 19.0% | 21.3% | | Net operating income as an ROE (excluding AOCI) | 14.1% | 14.3% | Book Value Per Share Comparison | Metric | March 31, 2025 | March 31, 2024 | | :--- | :--- | :--- | | Book value per share | $64.50 | $53.03 | | Book value per share, excluding AOCI | $87.92 | $79.00 | - Management utilizes non-GAAP measures like shareholders' equity excluding AOCI to better identify trends by removing fluctuations from interest rate changes[12](index=12&type=chunk) [Insurance Operations Analysis](index=4&type=section&id=INSURANCE%20OPERATIONS:) [Overall Insurance Performance](index=4&type=section&id=INSURANCE%20UNDERWRITING%20INCOME) Total insurance premium revenue grew 5% year-over-year to $1.2 billion, with life insurance premiums up 3% and health insurance premiums up 8%. Life insurance constitutes 69% of total premium revenue and 80% of the underwriting margin. Overall insurance underwriting income increased by 4% to $336.3 million, while net health sales saw a strong 24% increase, contrasting with a 1% decline in net life sales Q1 Insurance Premium Revenue (in thousands) | Product Type | Q1 2025 | Q1 2024 | % Change | | :--- | :--- | :--- | :--- | | Life insurance | $829,863 | $804,265 | 3% | | Health insurance | $369,791 | $341,019 | 8% | | **Total** | **$1,199,654** | **$1,145,284** | **5%** | Q1 Insurance Underwriting Income (in thousands) | Segment | Q1 2025 | Q1 2024 | % Change | | :--- | :--- | :--- | :--- | | Life Underwriting Margin | $337,264 | $309,011 | 9% | | Health Underwriting Margin | $84,721 | $93,770 | (10)% | | **Insurance Underwriting Income** | **$336,315** | **$324,361** | **4%** | - The ratio of administrative expenses to premium increased to **7.3%** in Q1 2025 from 7.0% in Q1 2024[20](index=20&type=chunk) [Life Insurance Segment](index=5&type=section&id=LIFE%20INSURANCE%20RESULTS%20BY%20DISTRIBUTION%20CHANNEL) Life insurance premiums increased by 3% to $830 million, driven by 6% growth in both the American Income and Liberty National divisions. However, total net life sales declined by 1%, with a notable 12% drop in the Direct to Consumer channel. Despite the mixed sales results, the total life underwriting margin improved by 9% to $337 million, with the margin percentage rising to 41% from 38% Q1 Life Premium by Distribution Channel (in thousands) | Channel | Q1 2025 | Q1 2024 | % Change | | :--- | :--- | :--- | :--- | | American Income | $437,866 | $414,044 | 6% | | Direct to Consumer | $245,600 | $248,040 | (1)% | | Liberty National | $96,182 | $90,777 | 6% | | **Total** | **$829,863** | **$804,265** | **3%** | Q1 Life Net Sales by Distribution Channel (in thousands) | Channel | Q1 2025 | Q1 2024 | % Change | | :--- | :--- | :--- | :--- | | American Income | $98,555 | $97,195 | 1% | | Direct to Consumer | $25,175 | $28,563 | (12)% | | Liberty National | $22,469 | $21,605 | 4% | | **Total** | **$148,351** | **$149,497** | **(1)%** | Q1 Life Underwriting Margin by Distribution Channel (in thousands) | Channel | Q1 2025 | % of Premium | Q1 2024 | % of Premium | % Change | | :--- | :--- | :--- | :--- | :--- | :--- | | American Income | $196,169 | 45% | $187,068 | 45% | 5% | | Direct to Consumer | $64,200 | 26% | $58,585 | 24% | 10% | | **Total** | **$337,264** | **41%** | **$309,011** | **38%** | **9%** | [Health Insurance Segment](index=6&type=section&id=HEALTH%20INSURANCE%20RESULTS%20BY%20DISTRIBUTION%20CHANNEL) Health insurance operations showed strong top-line growth, with premiums up 8% to $370 million and net sales surging 24% to $67 million. The growth was led by the United American division, which saw a 13% increase in premiums and a 69% jump in net sales. Despite this sales momentum, the total health underwriting margin declined by 10% to $84.7 million, with the margin percentage falling to 23% from 27%, primarily due to a significant drop in United American's margin Q1 Health Premium by Distribution Channel (in thousands) | Channel | Q1 2025 | Q1 2024 | % Change | | :--- | :--- | :--- | :--- | | United American | $159,848 | $141,635 | 13% | | Family Heritage | $112,354 | $103,391 | 9% | | **Total** | **$369,791** | **$341,019** | **8%** | Q1 Health Net Sales by Distribution Channel (in thousands) | Channel | Q1 2025 | Q1 2024 | % Change | | :--- | :--- | :--- | :--- | | United American | $27,708 | $16,423 | 69% | | Family Heritage | $26,816 | $24,966 | 7% | | **Total** | **$67,237** | **$54,400** | **24%** | Q1 Health Underwriting Margin by Distribution Channel (in thousands) | Channel | Q1 2025 | % of Premium | Q1 2024 | % of Premium | % Change | | :--- | :--- | :--- | :--- | :--- | :--- | | United American | $1,617 | 1% | $11,906 | 8% | (86)% | | Family Heritage | $39,249 | 35% | $35,838 | 35% | 10% | | **Total** | **$84,721** | **23%** | **$93,770** | **27%** | **(10)%** | [Agent Productivity](index=7&type=section&id=PRODUCING%20EXCLUSIVE%20AGENT%20COUNT%20RESULTS%20BY%20DISTRIBUTION%20CHANNEL) The company saw growth in its exclusive producing agent force compared to the prior year. The average producing agent count at American Income grew by 3% to 11,510. Liberty National and Family Heritage divisions experienced stronger growth, with agent counts increasing by 8% and 9% respectively Quarterly Average Producing Agent Count | Division | Q1 2025 | Q1 2024 | % Change | | :--- | :--- | :--- | :--- | | American Income | 11,510 | 11,139 | 3% | | Liberty National | 3,688 | 3,419 | 8% | | Family Heritage | 1,417 | 1,295 | 9% | [Investment Portfolio and Strategy](index=7&type=section&id=INVESTMENTS) [Investment Performance](index=7&type=section&id=Excess%20Investment%20Income) Excess investment income, a key measure of the investment segment's performance, decreased by 18% to $35.9 million in Q1 2025. On a per-share basis, it fell 9% to $0.42. This decline was driven by a 1% drop in net investment income coupled with a 2% increase in required interest on policy liabilities Q1 Excess Investment Income (in thousands, except per share) | Metric | Q1 2025 | Q1 2024 | % Change | | :--- | :--- | :--- | :--- | | Net investment income | $280,614 | $282,578 | (1)% | | Interest on policy liabilities | ($244,744) | ($238,793) | 2% | | **Excess investment income** | **$35,870** | **$43,785** | **(18)%** | | **Per share** | **$0.42** | **$0.46** | **(9)%** | - The fixed maturity portfolio earned an annual taxable equivalent effective yield of **5.25%** during Q1 2025, stable compared to 5.24% in the year-ago quarter[43](index=43&type=chunk) [Investment Portfolio Composition](index=8&type=section&id=Investment%20Portfolio) As of March 31, 2025, Globe Life's total investment portfolio stood at $20.0 billion. The portfolio is heavily weighted towards fixed maturities, which comprise 87% of the total at fair value. The quality of the fixed maturity portfolio remains high, with 97% of assets rated as 'investment grade' at both amortized cost and fair value Investment Portfolio Composition as of March 31, 2025 (in thousands) | Asset Class | Amount | % of Total | | :--- | :--- | :--- | | Fixed maturities at fair value | $17,504,967 | 87% | | Other long-term investments | $1,236,624 | 6% | | Policy loans | $708,175 | 4% | | Mortgage loans | $426,174 | 2% | | Short-term investments | $134,066 | 1% | | **Total** | **$20,010,006** | | - At amortized cost, **97%** of the **$19.0 billion** fixed maturity portfolio was rated investment grade. Corporate bonds make up the largest portion at **$15.1 billion**[42](index=42&type=chunk)[43](index=43&type=chunk) - The company is not a party to any credit default swaps and does not participate in securities lending[44](index=44&type=chunk) [Investment Acquisitions](index=9&type=section&id=Fixed%20Maturity%20Acquisitions) During the first quarter, the company acquired $244.8 million in fixed maturities, a decrease from $682.4 million in the prior-year quarter. These new investments have an average annual effective yield of 6.4% and an average rating of A-. The company also invested $52.0 million in other assets, primarily mortgage loans and limited partnerships Q1 Fixed Maturity Acquisitions | Metric | Q1 2025 | Q1 2024 | | :--- | :--- | :--- | | Amount (in thousands) | $244,845 | $682,427 | | Average annual effective yield | 6.4% | 5.9% | | Average rating | A- | A | Q1 Other Investment Acquisitions (in thousands) | Type | Q1 2025 | Q1 2024 | | :--- | :--- | :--- | | Limited partnerships | $15,831 | $67,498 | | Mortgage loans | $35,621 | $58,406 | | **Total** | **$51,954** | **$139,222** | [Capital Management and Outlook](index=9&type=section&id=SHARE%20REPURCHASE:) [Share Repurchase and Liquidity](index=9&type=section&id=LIQUIDITY/CAPITAL:) Globe Life continued its capital return program by repurchasing 1.5 million shares of its common stock for a total of $177 million during the quarter, at an average price of $121.70 per share. The company reports that its operations generate strong, stable cash flows, ensuring sufficient liquidity at the Parent Company level to meet the capital needs of its insurance subsidiaries - In Q1 2025, the company repurchased **1.5 million** common shares[50](index=50&type=chunk) - The total cost of the share repurchase was **$177 million**, at an average price of **$121.70 per share**[50](index=50&type=chunk) - The company's primary business of writing basic protection life and supplemental health insurance generates strong and stable cash flows, which are not impacted by volatile equity markets[51](index=51&type=chunk) [2025 Earnings Guidance](index=9&type=section&id=EARNINGS%20GUIDANCE%20FOR%20THE%20YEAR%20ENDING%20DECEMBER%2031,%202025:) Globe Life has reaffirmed its full-year 2025 earnings guidance. The company continues to project net operating income to be in the range of $13.45 to $14.05 per diluted common share - The company reaffirmed its previous guidance for the full year ending December 31, 2025[52](index=52&type=chunk) - Projected net operating income per diluted common share for 2025 is between **$13.45** and **$14.05**[52](index=52&type=chunk) [Appendix](index=12&type=section&id=APPENDIX) [GAAP Condensed Consolidated Statements of Operations](index=12&type=section&id=GLOBE%20LIFE%20INC.%20GAAP%20CONDENSED%20CONSOLIDATED%20STATEMENTS%20OF%20OPERATIONS) The GAAP condensed consolidated statement of operations shows total revenues of $1.48 billion for Q1 2025, an increase from $1.42 billion in Q1 2024. Net income remained flat at approximately $254 million for both periods. On a per-share basis, diluted net income was $3.01, up from $2.67 in the prior-year quarter Q1 GAAP Condensed Consolidated Statements of Operations (in thousands) | Metric | Q1 2025 | Q1 2024 | | :--- | :--- | :--- | | Total premium | $1,199,654 | $1,145,284 | | Total revenue | $1,480,422 | $1,416,139 | | Total benefits and expenses | $1,164,341 | $1,101,216 | | Income before income taxes | $316,081 | $314,923 | | **Net income** | **$254,563** | **$254,217** | | **Diluted net income per common share** | **$3.01** | **$2.67** |

Core Insights - Globe Life Inc. reported a net income of $3.01 per diluted common share for Q1 2025, an increase from $2.67 in the same quarter last year, while net operating income was $3.07 per diluted common share, exceeding management's expectations [1][6][11] Financial Performance - Net operating income increased by 10% year-over-year, from $2.78 to $3.07 per diluted common share [6][7] - Net income as a return on equity (ROE) was 19.0%, down from 21.3% in the previous year [6][11] - Total premium revenue for life insurance rose by 3% to $829.86 million, while health insurance premiums increased by 8% to $369.79 million, leading to a total premium revenue of $1.20 billion, a 5% increase from the previous year [13][43] Insurance Operations - Life insurance accounted for 80% of the insurance underwriting margin, while health insurance made up 20% [12] - Life underwriting margin increased by 9% year-over-year, while health underwriting margin decreased by 10% [15][19] - Net sales of life insurance declined by 1%, whereas net health sales increased by 24% [13][19] Investment Performance - Net investment income decreased by 1% to $280.61 million, while excess investment income fell by 18% to $35.87 million [25][26] - The investment portfolio totaled $20.01 billion, with fixed maturities making up 87% of the total [28][29] Shareholder Actions - The company repurchased 1.5 million shares of common stock at a total cost of $177 million, averaging $121.70 per share [34] - Shareholders' equity, excluding accumulated other comprehensive income (AOCI), was reported at $7.40 billion [11][12] Guidance - Globe Life projects net operating income between $13.45 to $14.05 per diluted common share for the year ending December 31, 2025, reaffirming previous guidance [36]

Company Overview - Globe Life Inc. is a holding company that specializes in life and supplemental health insurance targeting the middle-income market [2] - The company distributes its products through various channels, including direct-to-consumer sales and partnerships with exclusive and independent agencies [2] Annual Meeting Announcement - Globe Life Inc. will hold its 2025 Annual Meeting of Shareholders on April 24, 2025, at 10:00 AM Central [1] - The meeting will be accessible via a live audio webcast, and registration is required for both registered and beneficial shareholders as well as guests [1][3] - The meeting will adhere to the company's Shareholders' Rights Policy and Robert's Rules of Order [1]

Financial Results Announcement - Globe Life Inc. will announce its First Quarter 2025 financial results after the market closes on April 30, 2025 [1] - A copy of the earnings press release and other financial information will be available on the company's website [1] Conference Call Details - A live conference call will take place on May 1, 2025, at 12:00pm Eastern [2] - The call can be accessed by phone or online, with a replay available afterwards [2] Company Overview - Globe Life Inc. is a holding company that specializes in life and supplemental health insurance targeting the middle-income market [3] - The company distributes its products through various channels, including direct-to-consumer and both exclusive and independent agencies [3]

Core Viewpoint - Globe Life Inc. (GL) demonstrates strong investor confidence with its stock trading near a 52-week high, indicating potential for further price appreciation and solid upward momentum as it trades above key moving averages [1] Financial Performance - Earnings of Globe Life grew by 13.3% over the last five years, surpassing the industry average growth of 6.5% [2] - The stock has a solid track record of beating earnings estimates, achieving an average surprise of 4.36% in three of the last four quarters [2] Market Performance - Globe Life shares have gained 17% year to date, outperforming the industry decline of 5.3% and the Zacks S&P 500 composite's decline of 2.2% [3][4] Growth Projections - The Zacks Consensus Estimate for Globe Life's 2025 earnings per share indicates a year-over-year increase of 12.1%, with revenues projected at $6.08 billion, reflecting a 5.1% improvement [6] - For 2026, earnings per share and revenues are expected to increase by 8.5% and 5.1%, respectively, compared to 2025 estimates [6] Analyst Sentiment - Positive sentiment from analysts is evident, with six out of seven analysts raising estimates for 2025 and four for 2026 in the past 60 days, leading to a 2.3% and 0.9% upward revision in consensus estimates [7] Return on Capital - Globe Life's trailing 12-month return on equity stands at 21.9%, exceeding the industry average of 17.2%, indicating effective utilization of shareholder funds [8] - The return on invested capital (ROIC) is 13.1%, significantly higher than the industry average of 4.7%, reflecting efficient capital utilization [9] Valuation - Globe Life shares are trading at a price-to-book multiple of 9.22, lower than the industry average of 14.84, suggesting a favorable entry point for investors [10] Conclusion - Factors such as higher life and health sales, improved invested assets, increased productivity, strong liquidity, and effective capital deployment position Globe Life as an attractive investment opportunity [11] - The current affordability of the stock further supports the case for potential investment [12]

Core Insights - Value investing remains a preferred strategy for identifying strong stocks across various market conditions, focusing on companies perceived as undervalued based on fundamental analysis [2] - Zacks has developed a Style Scores system to highlight stocks with specific traits, particularly beneficial for value investors seeking stocks with high grades in the "Value" category [3] Company Analysis: Globe Life (GL) - Globe Life (GL) holds a Zacks Rank of 2 (Buy) and a Value grade of A, indicating strong potential for value investors [4] - The stock's Forward P/E ratio is 8.68, significantly lower than the industry's average of 13.86, with a 52-week range of 4.15 to 10.58 [4] - Globe Life's P/B ratio stands at 1.94, compared to the industry's average of 2.56, with a 52-week range of 0.92 to 2.61 [5] - The P/CF ratio for Globe Life is 7.01, which is attractive relative to the industry's average of 15.05, with a 52-week range of 3.39 to 8.79 [6] - These valuation metrics suggest that Globe Life is likely undervalued, supported by a strong earnings outlook, making it an impressive value stock [7]

Core Insights - Globe Life's Q4 2024 net operating income was $3.14 per share, exceeding estimates by 1.3% and showing a 12% year-over-year improvement driven by higher investment and underwriting income [2] - Total operating revenues for Q4 reached $1.4 billion, a 4.4% increase from the previous year, although it missed estimates by 1% [2] - The company reported a total premium revenue of $1.18 billion, up 4.5% year over year, primarily from life and health insurance premiums [3] Financial Performance - Net investment income rose 4% year over year to $282.4 million, while excess investment income increased by 7% to $38.3 million [3] - Total insurance underwriting income grew 3.1% year over year to $337.9 million, attributed to improved life underwriting income [4] - Administrative expenses increased by 18.3% year over year to $91.4 million, contributing to a total benefits and expenses rise of 7% to $1.1 billion [4] Segment Analysis - Life insurance premium revenues increased by 4% year over year to $822.9 million, with net sales rising 11% to $144.9 million [5] - Health insurance premium revenues grew by 7% year over year to $358.3 million, with net health sales increasing by 6% to $73.6 million [6] Shareholder Metrics - Shareholders' equity, excluding AOCI, increased by 1% year over year to $7.34 billion, with book value per share rising 13.4% to $86.40 [7] - The net operating return on equity, excluding AOCI, was 15.1%, expanding by 40 basis points year over year [7] Share Repurchase Activity - Globe Life repurchased 0.33 million shares worth $36 million during the reported quarter [8] Full-Year Performance - For the full year 2024, net operating income was $12.37 per share, a 16% increase year over year, with total operating revenues rising 5.2% to $5.8 billion [10] Future Outlook - The company estimates net operating income for 2025 to be in the range of $13.45-$14.05 per diluted common share [11] - Recent estimates have trended upward, indicating a positive outlook for the stock, which holds a Zacks Rank 2 (Buy) [12][14]

Insurance Premiums - Annualized premium in force for life insurance in 2024 reached $3,299,261,000, an increase of 3.5% from $3,185,745,000 in 2023[16] - Direct to Consumer channel for life insurance reported $922,508,000 in annualized premium in force in 2024, a slight decrease from $933,057,000 in 2023[16] - Health insurance annualized premium in force increased to $1,475,846,000 in 2024, up from $1,385,301,000 in 2023, representing a growth of 6.5%[22] - Limited-benefit plans accounted for 56% of the total supplemental health insurance premium in force in 2024, totaling $824,844,000[24] Agent and Employee Information - The company has 11,741 average producing agents in the U.S., Canada, and New Zealand for American Income Life Insurance Company[14] - The average producing agents for Liberty National Life Insurance Company totaled 3,664 in the U.S.[14] - As of December 31, 2024, Globe Life had 3,732 employees, a 3% increase from the previous year, primarily to support recent growth and lower attrition levels[43] - The company engaged over 16,400 independently-contracted insurance agents, which is critical for supporting sales growth in agency operations[43] - The company's board of directors consists of 9 independent members, with 56% being women and 33% being racial/ethnic minorities as of December 31, 2024[44] - The employee demographic as of December 31, 2024, included 51% White, 25% Black or African American, and 13% Hispanic or Latino[44] - The company emphasizes a diverse and inclusive workforce to achieve outstanding results, with 68% of employees being Baby Boomers and 44% Millennials[44] Investment and Financial Risks - Globe Life's investments consist predominantly of high-quality, investment-grade securities, with approximately 88% of invested assets in fixed maturities as of December 31, 2024[30] - Globe Life's investment portfolio is predominantly in fixed income, exposing it to market and credit risks, which could impact net investment income[61] - Changes in interest rates could negatively affect the company's income and liquidity, impacting policyholder behavior and investment returns[64][66] - The ability to fund operations is heavily reliant on the surplus and earnings of its insurance subsidiaries, which are subject to regulatory restrictions on dividend payments[68] - Adverse capital and credit market conditions may significantly affect the company's liquidity needs and cost of capital, potentially reducing net income if interest rates increase[72] - The company may need to seek additional financing if current liquidity sources are insufficient, which could be impacted by market conditions and credit availability[73] Regulatory and Legal Risks - The company faces risks related to the misclassification of independent contractors, which could lead to legal and financial consequences[56] - A downgrade by rating agencies could limit the ability of the company's insurance subsidiaries to pay dividends and adversely affect sales of insurance products[79] - Changes in regulations or regulatory scrutiny could materially impact the company's business and financial condition[86] - Negative publicity and allegations against the company could damage its brand and reputation, affecting agent recruitment and product sales[95] - Globe Life has no unresolved SEC staff comments as of December 31, 2024[99] - The company may face challenges in meeting evolving corporate responsibility and sustainability standards, which could impact its reputation and financial performance[97] - Failure to achieve corporate responsibility expectations could lead to scrutiny from regulators, investors, and the public, resulting in potential legal challenges[97] Operational and Market Risks - Variations in mortality, morbidity, and policyholder behavior could materially affect the company's financial condition and results of operations due to reliance on actuarial estimates[78] - Timely premium rate increases for Medicare Supplement insurance are critical; failure to obtain these could negatively impact profitability[80] - The company is exposed to catastrophic events that could significantly impact financial results, particularly in the case of pandemics or natural disasters[81] - The company faces risks related to model errors and limitations, which could lead to financial loss or reputational damage[83] - The company has been targeted by short sellers since April 2024, resulting in a significant decline in stock price and negative publicity, which has damaged its reputation[76]

Core Viewpoint - Kaskela Law LLC is investigating Globe Life Inc. for potential securities fraud and misconduct related to misleading statements made to investors between May 8, 2019, and April 10, 2024 [2][4]. Group 1: Allegations and Complaints - A securities fraud complaint has been filed against Globe Life, alleging that the company and its executives issued materially false and misleading statements in violation of federal securities laws [2]. - The complaint details that Globe Life engaged in widespread insurance fraud, including adding policies to existing users' accounts without consent and underwriting policies for deceased or fictitious individuals [3]. - The report also claims that Globe Life maintained a hostile workplace environment characterized by unchecked sexual harassment, drug use, and sexual assault [3]. Group 2: Financial Impact - Following the allegations reported by Fuzzy Panda, Globe Life's stock price plummeted by $55.76 per share, representing a 53% decrease, closing at $49.17 per share on April 10, 2024, with unusually high trading volume [4]. Group 3: Legal Actions - The investigation aims to determine if Globe Life's board of directors violated securities laws or breached their fiduciary duties in relation to the alleged misconduct [4]. - Shareholders who acquired Globe Life shares before April 11, 2024, are encouraged to contact Kaskela Law LLC for information regarding their legal rights and options [5].

Company Overview - Globe Life Inc. is a Texas-based life insurance company, headquartered in McKinney, TX, with over 15,000 insurance agents and 3,000 corporate employees [9] - The company has a mission to "Make Tomorrow Better" and is committed to uplifting communities and supporting veterans and service members [2][4] - Globe Life issues more life insurance policies than any other company in the U.S., with over 17 million policies in force [9] Recent Partnership - Globe Life has pledged $2 million to the National Medal of Honor Museum Foundation (NMOHMF) in recognition of its commitment to honoring those who have made the ultimate sacrifice [1][4] - The donation will be recognized by naming the stage at the Museum's Neel Kearby Theater after Globe Life [1] - This partnership aligns with Globe Life's purpose-driven mission and reflects its values of service and leadership [2][4] National Medal of Honor Museum - The National Medal of Honor Museum is set to open in March 2025, featuring over 100,000 square feet of space, including 31,000 square feet for Exhibition Galleries [4][6] - The Museum aims to inspire visitors by telling the stories of Medal of Honor recipients in a dynamic and interactive setting [6] - The Museum will serve as a national landmark in Arlington, Texas, commemorating sacrifice, patriotism, and courage [6]